Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 43

1.

Anti-VEGF treatment for myopic choroid neovascularization: from molecular characterization to update on clinical application.

Zhang Y, Han Q, Ru Y, Bo Q, Wei RH.

Drug Des Devel Ther. 2015 Jul 2;9:3413-21. doi: 10.2147/DDDT.S87920. eCollection 2015. Review.

2.

Aflibercept in wet AMD beyond the first year of treatment: recommendations by an expert roundtable panel.

McKibbin M, Devonport H, Gale R, Gavin M, Lotery A, Mahmood S, Patel PJ, Ross A, Sivaprasad S, Talks J, Walters G.

Eye (Lond). 2015 Jul;29 Suppl 1:S1-S11. doi: 10.1038/eye.2015.77. Review.

3.

Strategies for improving early detection and diagnosis of neovascular age-related macular degeneration.

Keane PA, de Salvo G, Sim DA, Goverdhan S, Agrawal R, Tufail A.

Clin Ophthalmol. 2015 Feb 17;9:353-66. doi: 10.2147/OPTH.S59012. eCollection 2015. Review.

4.

Management of colorectal cancer.

Stintzing S.

F1000Prime Rep. 2014 Nov 4;6:108. doi: 10.12703/P6-108. eCollection 2014. Review.

5.

Incidence and management of ZIv-aflibercept related toxicities in colorectal cancer.

Saif MW, Relias V, Syrigos K, Gunturu KS.

World J Clin Oncol. 2014 Dec 10;5(5):1028-35. doi: 10.5306/wjco.v5.i5.1028. Review.

6.

Vascular endothelial growth factor trap-eye and trap technology: Aflibercept from bench to bedside.

Al-Halafi AM.

Oman J Ophthalmol. 2014 Sep;7(3):112-5. doi: 10.4103/0974-620X.142591. Review.

7.

MicroRNAs as novel predictive biomarkers and therapeutic targets in colorectal cancer.

Stiegelbauer V, Perakis S, Deutsch A, Ling H, Gerger A, Pichler M.

World J Gastroenterol. 2014 Sep 7;20(33):11727-35. doi: 10.3748/wjg.v20.i33.11727. Review.

8.

Targeting angiogenesis and tumor microenvironment in metastatic colorectal cancer: role of aflibercept.

Giordano G, Febbraro A, Venditti M, Campidoglio S, Olivieri N, Raieta K, Parcesepe P, Imbriani GC, Remo A, Pancione M.

Gastroenterol Res Pract. 2014;2014:526178. doi: 10.1155/2014/526178. Epub 2014 Jul 21. Review.

9.

Which strategy after first-line therapy in advanced colorectal cancer?

Andrea C, Fausto P, Francesca BK, Mary C, Mara G, Veronica L, Sandro B.

World J Gastroenterol. 2014 Jul 21;20(27):8921-7. doi: 10.3748/wjg.v20.i27.8921. Review.

10.

Targeting metastatic colorectal cancer - present and emerging treatment options.

Ciombor KK, Berlin J.

Pharmgenomics Pers Med. 2014 Jul 8;7:137-44. doi: 10.2147/PGPM.S47582. eCollection 2014. Review.

11.

Ziv-aflibercept use in metastatic colorectal cancer.

Rodriguez M.

J Adv Pract Oncol. 2013 Sep;4(5):348-52. Review. No abstract available.

12.

Advances and new perspectives in the treatment of metastatic colon cancer.

Recondo G Jr, Díaz-Cantón E, de la Vega M, Greco M, Recondo G Sr, Valsecchi ME.

World J Gastrointest Oncol. 2014 Jul 15;6(7):211-24. doi: 10.4251/wjgo.v6.i7.211. Review.

13.

Bevacizumab in combination with chemotherapy for the treatment of advanced ovarian cancer: a systematic review.

Aravantinos G, Pectasides D.

J Ovarian Res. 2014 May 19;7:57. doi: 10.1186/1757-2215-7-57. eCollection 2014. Review.

14.

Anti-vascular endothelial growth factor for macular oedema secondary to central retinal vein occlusion.

Braithwaite T, Nanji AA, Lindsley K, Greenberg PB.

Cochrane Database Syst Rev. 2014 May 1;5:CD007325. doi: 10.1002/14651858.CD007325.pub3. Review.

15.

Sequencing of antiangiogenic agents in the treatment of metastatic colorectal cancer.

Lee JJ, Chu E.

Clin Colorectal Cancer. 2014 Sep;13(3):135-44. doi: 10.1016/j.clcc.2014.02.001. Epub 2014 Feb 27. Review.

16.

Anti-angiogenesis in prostate cancer: knocked down but not out.

Bilusic M, Wong YN.

Asian J Androl. 2014 May-Jun;16(3):372-7. doi: 10.4103/1008-682X.125903. Review.

17.

Anti-VEGF for the management of diabetic macular edema.

Stefanini FR, Badaró E, Falabella P, Koss M, Farah ME, Maia M.

J Immunol Res. 2014;2014:632307. doi: 10.1155/2014/632307. Epub 2014 Feb 5. Review.

18.

Sequencing of treatment in metastatic colorectal cancer: where to fit the target.

Temraz S, Mukherji D, Shamseddine A.

World J Gastroenterol. 2014 Feb 28;20(8):1993-2004. doi: 10.3748/wjg.v20.i8.1993. Review.

19.

Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions.

Vasudev NS, Reynolds AR.

Angiogenesis. 2014 Jul;17(3):471-94. doi: 10.1007/s10456-014-9420-y. Epub 2014 Jan 31. Review. Erratum in: Angiogenesis. 2014 Jul;17(3):495-7.

20.

Current and Novel Treatment Options for Metastatic Colorectal Cancer: Emphasis on Aflibercept.

Dietvorst MH, Eskens FA.

Biol Ther. 2013;3:25-33. Epub 2013 Feb 28. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk